Wilbanks Smith & Thomas Asset Management LLC Mesoblast LTD Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$6.69 - $9.0 $66,900 - $90,000	-10,000 Reduced 36.37%	17,498 $131,000
Q1 2021 May 11, 2021	SELL	$8.26 - $11.4 $20,666 - $28,522	-2,502 Reduced 8.34%	27,498 $227,000
Q4 2020 Feb 12, 2021	SELL	$8.21 - $18.59 $20,254 - $45,861	-2,467 Reduced 7.6%	30,000 $255,000
Q3 2020 Nov 12, 2020	BUY	$11.33 - $19.81 $50,611 - $88,491	4,467 Added 15.95%	32,467 $603,000
Q2 2020 Jul 31, 2020	SELL	$4.2 - $15.45 $105,000 - $386,250	-25,000 Reduced 47.17%	28,000 $319,000
Q1 2020 May 06, 2020	BUY	$3.38 - $10.63 $94,555 - $297,374	27,975 Added 111.79%	53,000 $232,000
Q4 2019 Feb 13, 2020	BUY	$5.74 - $7.42 $8,179 - $10,573	1,425 Added 6.04%	25,025 $184,000
Q3 2019 Nov 06, 2019	BUY	$4.68 - $7.42 $110,448 - $175,112	23,600 New	23,600 $164,000

Others Institutions Holding MESO

# of Institutions

Shares Held

151K

Call Options Held

Put Options Held

View Full List

About MESOBLAST LTD

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

More about MESO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account